• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-1 通过靶向纤连蛋白抑制神经胶质瘤在临床前模型中的生长。

MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin.

机构信息

Department of Pathology and Laboratory Medicine, The Center for Cancer Research, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

Department of Pathology and Laboratory Medicine, The Center for Cancer Research, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.

出版信息

Cancer Lett. 2019 Nov 28;465:59-67. doi: 10.1016/j.canlet.2019.08.021. Epub 2019 Sep 3.

DOI:10.1016/j.canlet.2019.08.021
PMID:31491450
Abstract

Glioblastoma (GBM) is a deadly and incurable brain tumor. Although microRNAs (miRNAs) play critical roles in regulating the cancer cell phenotype, the underlying mechanisms of how they regulate tumorigenesis are incompletely understood. We found that miR-1 is expressed at relatively low levels in brain cancer patients, especially GBM. Ectopic miR-1 expression in GBM cells inhibited proliferation and migration, increased sensitivity to apoptosis induced by the DNA alkylating agent temozolomide in vitro, and inhibited GBM tumorigenesis in vivo. Expression of miR-1 in GBM cell lines directly targets fibronectin. High fibronectin expression in GBM correlates with poor patient survival and fibronectin expression is inversely correlated with miR-1 expression. Knockout of fibronectin expression in GBM cell lines inhibited proliferation and migration, increased sensitivity to apoptosis induced by temozolomide in vitro, and markedly suppressed GBM tumor growth and promoted animal survival. In contrast, restoring fibronectin levels in GBM cells ectopically expressing miR-1 increased tumorigenicity and decreased animal survival. Therefore, these results confirm that miR-1 has tumor suppressive activity in GBM by targeting fibronectin, and that the miR-1/fibronectin pathway may be a potential drug target in this devastating cancer.

摘要

胶质母细胞瘤(GBM)是一种致命且无法治愈的脑肿瘤。虽然 microRNAs(miRNAs)在调节癌细胞表型方面发挥着关键作用,但它们调节肿瘤发生的潜在机制尚不完全清楚。我们发现,miR-1 在脑癌患者,尤其是 GBM 患者中的表达水平相对较低。在 GBM 细胞中异位表达 miR-1 可抑制增殖和迁移,增加体外 DNA 烷化剂替莫唑胺诱导的细胞凋亡敏感性,并抑制体内 GBM 肿瘤发生。miR-1 在 GBM 细胞系中的表达直接靶向纤维连接蛋白。GBM 中高纤维连接蛋白表达与患者生存不良相关,纤维连接蛋白表达与 miR-1 表达呈负相关。在 GBM 细胞系中敲除纤维连接蛋白表达可抑制增殖和迁移,增加体外替莫唑胺诱导的细胞凋亡敏感性,并显著抑制 GBM 肿瘤生长和促进动物存活。相比之下,在异位表达 miR-1 的 GBM 细胞中恢复纤维连接蛋白水平可增加致瘤性并降低动物存活率。因此,这些结果证实 miR-1 通过靶向纤维连接蛋白在 GBM 中具有肿瘤抑制活性,miR-1/纤维连接蛋白途径可能是这种毁灭性癌症的潜在药物靶点。

相似文献

1
MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin.MicroRNA-1 通过靶向纤连蛋白抑制神经胶质瘤在临床前模型中的生长。
Cancer Lett. 2019 Nov 28;465:59-67. doi: 10.1016/j.canlet.2019.08.021. Epub 2019 Sep 3.
2
MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.微小 RNA-128-3p 通过靶向 c-Met 和 EMT 增强胶质母细胞瘤对替莫唑胺的化疗敏感性。
Sci Rep. 2020 Jun 11;10(1):9471. doi: 10.1038/s41598-020-65331-3.
3
miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.miR-126-3p 通过靶向 SOX2 使胶质母细胞瘤细胞对替莫唑胺敏感,从而使 Wnt/β-catenin 信号失活。
Life Sci. 2019 Jun 1;226:98-106. doi: 10.1016/j.lfs.2019.04.023. Epub 2019 Apr 10.
4
MicroRNA203a suppresses glioma tumorigenesis through an ATM-dependent interferon response pathway.微小RNA203a通过一条依赖于共济失调毛细血管扩张突变基因(ATM)的干扰素反应途径抑制神经胶质瘤的肿瘤发生。
Oncotarget. 2017 Dec 6;8(68):112980-112991. doi: 10.18632/oncotarget.22945. eCollection 2017 Dec 22.
5
miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.miR-504 通过直接靶向 FZD7 介导的 Wnt-β-catenin 通路抑制胶质母细胞瘤的间充质表型。
J Exp Clin Cancer Res. 2019 Aug 16;38(1):358. doi: 10.1186/s13046-019-1370-1.
6
Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.Mir-758-5p通过靶向ZBTB20抑制胶质母细胞瘤的增殖、迁移和侵袭。
Cell Physiol Biochem. 2018;48(5):2074-2083. doi: 10.1159/000492545. Epub 2018 Aug 10.
7
MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.微小 RNA-193a-5p 通过调节 NOVA1 在胶质母细胞瘤中发挥肿瘤抑制作用。
J Cell Biochem. 2019 Apr;120(4):6188-6197. doi: 10.1002/jcb.27906. Epub 2018 Oct 10.
8
MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.微小RNA203抑制胶质母细胞瘤中促肿瘤性信号转导和转录激活因子1的表达以抑制肿瘤发生。
Oncotarget. 2016 Dec 20;7(51):84017-84029. doi: 10.18632/oncotarget.12401.
9
MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.微小 RNA-518b 通过靶向 PDGFRB 在胶质母细胞瘤中发挥肿瘤抑制作用。
Mol Med Rep. 2017 Oct;16(4):5326-5332. doi: 10.3892/mmr.2017.7298. Epub 2017 Aug 21.
10
Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.外泌体miR-1238 的转移促进胶质母细胞瘤对替莫唑胺的耐药性。
EBioMedicine. 2019 Apr;42:238-251. doi: 10.1016/j.ebiom.2019.03.016. Epub 2019 Mar 24.

引用本文的文献

1
Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1/miR-26a-1/miR-487b signature mediated WT1 and FOXA1 silencing.雄激素受体抑制通过miR-1/miR-26a-1/miR-487b信号介导的WT1和FOXA1沉默使胶质母细胞瘤干细胞对替莫唑胺敏感。
Cell Death Discov. 2025 May 21;11(1):248. doi: 10.1038/s41420-025-02517-6.
2
The Clinical Role of miRNAs in the Development and Treatment of Glioblastoma.微小RNA在胶质母细胞瘤发生发展及治疗中的临床作用
Int J Mol Sci. 2025 Mar 18;26(6):2723. doi: 10.3390/ijms26062723.
3
Network Pharmacology to Unveil the Mechanism of Berberine in the Treatment of Meningitis in Humans and Pigs.
网络药理学揭示小檗碱治疗人和猪脑膜炎的机制
Toxics. 2025 Feb 15;13(2):138. doi: 10.3390/toxics13020138.
4
Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy.血清 miRNA-1 可能成为一种有前途的非侵入性生物标志物,可用于预测接受新辅助化疗的乳腺癌患者的治疗反应。
BMC Cancer. 2024 Jul 2;24(1):789. doi: 10.1186/s12885-024-12500-6.
5
Targets in the Tumour Matrisome to Promote Cancer Therapy Response.肿瘤基质组中促进癌症治疗反应的靶点。
Cancers (Basel). 2024 May 11;16(10):1847. doi: 10.3390/cancers16101847.
6
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway.miRNA-660-3p 通过负向调控 APOC1-TGFβ2 信号通路抑制胶质母细胞瘤的恶性程度。
Cancer Biol Ther. 2023 Dec 31;24(1):2281459. doi: 10.1080/15384047.2023.2281459. Epub 2023 Nov 19.
7
The important role of miR-1-3p in cancers.miR-1-3p 在癌症中的重要作用。
J Transl Med. 2023 Oct 31;21(1):769. doi: 10.1186/s12967-023-04649-8.
8
A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma.miRNAs 及其在胶质母细胞瘤中的表观遗传效应的综合综述。
Cells. 2023 Jun 7;12(12):1578. doi: 10.3390/cells12121578.
9
MiR-217 regulates autophagy through OPG/RANKL/RANK in giant cell tumors.miR-217 通过 OPG/RANKL/RANK 在破骨细胞瘤中调控自噬。
J Orthop Surg Res. 2023 May 10;18(1):346. doi: 10.1186/s13018-023-03826-1.
10
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.一种诊断性循环 miRNA 特征作为人类神经胶质瘤中 TKS4/TKS5/EFHD2 调节细胞侵袭的协调因子。
J Exp Clin Cancer Res. 2023 Mar 17;42(1):66. doi: 10.1186/s13046-023-02639-8.